Etiology and impact of cytomegalovirus disease on solid organ transplant recipients (Q36600835)

15 August 2017

1 reference

title

Etiology and impact of cytomegalovirus disease on solid organ transplant recipients (English)

1 reference

15 August 2017

0 references

Lisa M McDevitt

1

1 reference

15 August 2017

1 October 2006

1 reference

American Journal of Health-System Pharmacy

15 August 2017

1 reference

15 August 2017

63

1 reference

15 August 2017

19 Suppl 5

1 reference

15 August 2017

S3-9

1 reference

Epstein-Barr virus-associated T-cell lymphoma in solid organ transplant recipients

15 August 2017

1 reference

https://api.crossref.org/works/10.2146%2FAJHP060377

Human herpesvirus 8: biology and role in the pathogenesis of Kaposi's sarcoma and other AIDS-related malignancies

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP060377

Diagnostic approaches to cytomegalovirus infection in bone marrow and organ transplantation

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP060377

Canadian society of transplantation consensus workshop on cytomegalovirus management in solid organ transplantation final report

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP060377

A prospective study of the natural course of cytomegalovirus infection and disease in renal allograft recipients

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP060377

Infections in solid-organ transplant recipients

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP060377

Infection in solid organ transplantation.

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP060377

Valacyclovir for the prevention of cytomegalovirus disease after renal transplantation. International Valacyclovir Cytomegalovirus Prophylaxis Transplantation Study Group.

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP060377

Randomised trial of efficacy and safety of oral ganciclovir in the prevention of cytomegalovirus disease in liver-transplant recipients. The Oral Ganciclovir International Transplantation Study Group [corrected].

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP060377

Late and atypical cytomegalovirus disease in solid-organ transplant recipients

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP060377

Exposure to cytomegalovirus from the donated organ is a risk factor for bacteremia in orthotopic liver transplant recipients. Boston Center for Liver Transplantation CMVIG Study Group

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP060377

The clinical impact of ganciclovir prophylaxis on the occurrence of bacteremia in orthotopic liver transplant recipients.

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP060377

Risk factors of invasive Candida and non-Candida fungal infections after liver transplantation.

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP060377

Risk factors for invasive fungal infections complicating orthotopic liver transplantation.

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP060377

The independent role of cytomegalovirus as a risk factor for invasive fungal disease in orthotopic liver transplant recipients. Boston Center for Liver Transplantation CMVIG-Study Group. Cytogam, MedImmune, Inc. Gaithersburg, Maryland.

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP060377

Risk factors of invasive aspergillosis after heart transplantation: protective role of oral itraconazole prophylaxis

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP060377

Cytomegalovirus infection is a risk factor for invasive aspergillosis in lung transplant recipients.

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP060377

Risk factors for invasive aspergillosis in liver transplant recipients

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP060377

Human beta-herpesvirus interactions in solid organ transplant recipients

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP060377

Association of human herpesvirus 6 reactivation with severe cytomegalovirus-associated disease in orthotopic liver transplant recipients.

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP060377

PROSPECTIVE STUDY OF HUMAN BETAHERPESVIRUSES AFTER RENAL TRANSPLANTATION

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP060377

Coincidence of Epstein-Barr virus reactivation, cytomegalovirus infection, and rejection episodes in renal transplant recipients.

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP060377

Posttransplant lymphoproliferative disease in primary Epstein-Barr virus infection after liver transplantation: the role of cytomegalovirus disease

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP060377

The pathogenesis of hepatitis C virus is influenced by cytomegalovirus

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP060377

Reassessing the impact of cytomegalovirus infection in kidney and kidney-pancreas transplantation

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP060377

The impact of cytomegalovirus infection and disease on rejection episodes in renal allograft recipients

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP060377

Cytomegalovirus infection--an etiological factor for rejection? A prospective study in 242 renal transplant patients

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP060377

Cytomegalovirus infection and graft rejection in renal transplantation

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP060377

Valacyclovir for cytomegalovirus prophylaxis reduces the risk of acute renal allograft rejection

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP060377

Cytomegalovirus disease after prophylaxis with oral ganciclovir in renal transplantation: the importance of HLA-DR matching

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP060377

Association between cytomegalovirus disease and chronic rejection in kidney transplant recipients

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP060377

Association of cytomegalovirus disease and acute rejection with graft loss in kidney transplantation

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP060377

Cardiac allograft vasculopathy and dysregulation of the NO synthase pathway

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP060377

Role of cytomegalovirus infection in allograft rejection: a review of possible mechanisms

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP060377

Cytomegalovirus and chronic allograft rejection in liver transplantation

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP060377

Bronchiolitis obliterans syndrome: risk factors and therapeutic strategies

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP060377

Cytomegalovirus prophylaxis and graft outcome in solid organ transplantation: a collaborative transplant study report

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP060377

Effect of cytomegalovirus infection status on first-year mortality rates among orthotopic liver transplant recipients. The Boston Center for Liver Transplantation CMVIG Study Group

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP060377

Cytomegalovirus infection and pneumonitis. Impact after isolated lung transplantation. Washington University Lung Transplant Group

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP060377

Prevalence of BK virus replication among recipients of solid organ transplants

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP060377

Changes in the incidence and severity of recurrent hepatitis C after liver transplantation over 1990-1999.

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP060377

31 March 2020

Identifiers

DOI

10.2146/AJHP060377

1 reference

release_2xpowa767zdxbjomvshxppgejq

15 August 2017

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/2xpowa767zdxbjomvshxppgejq

mapped directly with Wikidata item

24 November 2022

based on heuristic

PubMed ID

16990643

1 reference

PubMed ID

16990643